New User? Sign Up Free
SCCM is performing maintenance on its websites. For the best browsing experience, please use Microsoft Edge or Safari. Those using Chrome or Firefox may experience access issues at this time.
Monica Vavilala, MD, discusses her recent article published in the May issue of Pediatric Critical Care Medicine, titled “Change in Blood-Brain Barrier Permeability During Pediatric Diabetic Ketoacidosis Treatment.” Vavilala is an associate professor of anesthesiology, pain medicine and pediatrics at Harborview Medical Center, and is the associate director of the Harborview Injury Prevention and Research Center in Seattle, Washington. She is also an adjunct associate professor of neurological surgery at the University of Washington.
Kuppermann et al (N Engl J Med. 2018;378:2275-2287) sought to prospectively determine the role that fluid makeup and rate have on the development of neurologic injury in children with DKA.
Ludwig Lin, MD, speaks with Palash Kar, MBBS, about the article, “Liberal Glycemic Control in Critically Ill Patients With Type 2 Diabetes: An Exploratory Study," published in Critical Care Medicine. In this article, Dr. Kar and coauthors found that in critically ill patients with type 2 diabetes and chronic hyperglycemia, liberal glycemic control appears to attenuate glycemic variability and may reduce the prevalence of moderate-severe hypoglycemia. Dr. Kar is a senior registrar in intensive care at Royal Adelaide Hospital in South Australia. Dr. Kar has no relevant disclosures. Crit Care Med. 2016; 44(9):1695-1703. Released: 1/25/18
Margaret Parker, MD, MCCM, speaks with Martha Curley, RN, PhD, Professor of Nursing Science at the University of Pennsylvania School of Nursing in Philadelphia and Nurse Scientist at Children's Hospital in Boston. Dr. Curley discusses "Protocolized Sedation vs Usual Care in Pediatric Patients Mechanically Ventilated for Acute Respiratory Failure: A Randomized Clinical Trial," published January 2015 in The Journal of the American Medical Association. Dr. Curley presented the article on behalf of her co-investigators at the 44th Critical Care Congress in Phoenix, Arizona.
Jeffrey Guy, MD, MSc, MMHC, speaks with Omar Badawi, PharmD, MPH, to discuss his article published in the December Critical Care Medicine, “Association Between ICU-Acquired Dysglycemia and In-Hospital Mortality.” Study results suggest severe ICU-acquired hyperglycemia, hypoglycemia and variability are associated with a higher risk of mortality. Badawi works for Phillips Healthcare in Baltimore, Maryland, USA.
Margaret Parker, MD, FCCM, speaks with Eliotte L. Hirshberg, MD, about her article “Clinical Equipoise Regarding Glycemic Control: A Survey of Pediatric Intensivist Perceptions,” which was published in the February 2013 issue of Pediatric Critical Care Medicine. The aim of the study was to see whether adult literature had impacted pediatric intensivists practices regarding blood glucose control. Hirshberg is an assistant professor of internal medicine at the University of Utah with an adjunct assistant professor appointment in the Department of Pediatrics in Salt Lake City, Utah. Hirshberg is also board certified as both an adult and pediatric intensive care unit (ICU) physician, working at both the Primary Children’s Medical Center Pediatric ICU as well as Intermountain Medical Center’s Shock-Trauma ICU for adults.
Jeffrey Guy, MD, MSc, MMHC, speaks with Judith Jacobi, PharmD, FCCM, lead author on the new glycemic control guidelines from the Society of Critical Care Medicine's American College of Critical Care Medicine titled, “Guidelines for the Use of an Insulin Infusion for the Management of Hyperglycemia in Critically Ill Patients,” published in the December Critical Care Medicine. The task force provides suggestions for the structure of safe and effective use of insulin infusion therapy in patients requiring tight glycemic control. Jacobi is a critical care pharmacy specialist at Indiana University Health Methodist Hospital in Indianapolis, Indiana. She is also a past president of the Society of Critical Care Medicine.
From Critical Care Medicine. In this Online Letter to the Editor, the authors write in response to an article by Frontera et al. in Critical Care Medicine about etiology of hyponatremia in coronavirus disease 2019 (COVID-19) patients.
During the 2022 Critical Care Congress, Karin Reuter-Rice, PhD, NP, FAAN, FCCM, will talk about precision health, and specifically the role omic technologies play in critical care in a thought leader session titled “Genetics and Genomics.”
Crit Care Med 2018; 46(1):146-148
Crit Care Med 2017; 45(12):2078-2088
From Critical Care Explorations. In this study, the authors found prolonged reduced exercise capacity up to 6 months in critically ill coronavirus disease 2019 survivors. This disability did not result from residual pulmonary or cardiac dysfunction but rather from a metabolic disorder characterized by a sustained hypermetabolism and an impaired oxygen utilization.